Immunovant Inc
IMVTHealthcare|Biotechnology|USA
$39.71
-1.38 (-3.36%)
Tangible Book
$4.18
Earnings Power
$4.41
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (198)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Gloria Melanie | COO | 2026-07-08 | SELL | 2,036 | $39.55 | $80.5K |
| Van Tuyl Christopher | Chief Legal Officer | 2026-07-08 | SELL | 1,206 | $39.55 | $47.7K |
| Stout Jay S | Chief Technology Officer | 2026-07-08 | SELL | 3,487 | $39.55 | $137.9K |
| Venker Eric | CEO | 2026-07-02 | SELL | 3,092 | $38.48 | $119K |
| Gloria Melanie | COO | 2026-06-26 | SELL | 17,714 | $38.31 | $678.6K |
| Stout Jay S | Chief Technology Officer | 2026-06-26 | SELL | 40,000 | $38.31 | $1532.4K |
| Van Tuyl Christopher | Chief Legal Officer | 2026-06-26 | SELL | 17,824 | $38.31 | $682.8K |
| Girao Tiago | CFO | 2026-06-26 | SELL | 10,000 | $38.46 | $384.6K |
| Pande Atul | Director | 2026-06-26 | SELL | 1,500 | $38.01 | $57K |
| Van Tuyl Christopher | Chief Legal Officer | 2026-06-18 | SELL | 2,634 | $35.39 | $93.2K |
| Pande Atul | Director | 2026-06-15 | SELL | 1,500 | $34.02 | $51K |
| Fromkin Andrew J. | Director | 2026-05-28 | SELL | 221,951 | $33.51 | $7437.6K |
| Gloria Melanie | COO | 2026-05-20 | SELL | 3,115 | $32.45 | $101.1K |
| Pande Atul | Director | 2026-05-20 | SELL | 6,000 | $32 | $192K |
| Susman Robert Graham | Director | 2026-05-01 | SELL | 2,502 | $27.17 | $68K |
| Girao Tiago | CFO | 2026-04-23 | SELL | 25,760 | $29.62 | $763K |
| Stout Jay S | Chief Technology Officer | 2026-04-23 | SELL | 2,754 | $29.62 | $81.6K |
| Stout Jay S | Chief Technology Officer | 2026-04-08 | SELL | 10,132 | $24.83 | $251.6K |
| Van Tuyl Christopher | Chief Legal Officer | 2026-04-08 | SELL | 5,165 | $24.83 | $128.2K |
| Gloria Melanie | COO | 2026-04-08 | SELL | 8,722 | $24.83 | $216.6K |
| Venker Eric | CEO | 2026-04-02 | SELL | 14,229 | $24.1 | $342.9K |
| Van Tuyl Christopher | Chief Legal Officer | 2026-03-18 | SELL | 2,877 | $24.97 | $71.8K |
| Gloria Melanie | COO | 2026-02-25 | SELL | 3,238 | $27.85 | $90.2K |
| Stout Jay S | Chief Technology Officer | 2026-01-21 | SELL | 1,977 | $26.03 | $51.5K |
| Stout Jay S | Chief Technology Officer | 2026-01-07 | SELL | 1,203 | $26.53 | $31.9K |
| Van Tuyl Christopher | Chief Legal Officer | 2025-12-18 | SELL | 10,813 | $26.91 | $291K |
| Roivant Sciences Ltd. | Director, 10% Owner | 2025-12-12 | BUY | 16,666,666 | $21 | $350000K |
| Fromkin Andrew J. | Director | 2025-12-01 | SELL | 22,249 | $23.25 | $517.3K |
| Hughes Douglas J. | Director | 2025-12-01 | SELL | 15,000 | $23.24 | $348.6K |
| Gloria Melanie | COO | 2025-11-20 | SELL | 12,626 | $23.62 | $298.2K |
| Geffner Michael | Chief Medical Officer | 2025-10-22 | SELL | 2,595 | $19.03 | $49.4K |
| Stout Jay S | Chief Technology Officer | 2025-10-22 | SELL | 2,520 | $19.03 | $48K |
| Geffner Michael | Chief Medical Officer | 2025-10-08 | SELL | 1,272 | $16.3 | $20.7K |
| Stout Jay S | Chief Technology Officer | 2025-10-08 | SELL | 1,585 | $16.3 | $25.8K |
| Stout Jay S | Chief Technology Officer | 2025-07-23 | SELL | 2,805 | $18.15 | $50.9K |
| Geffner Michael | Chief Medical Officer | 2025-07-23 | SELL | 2,385 | $18.15 | $43.3K |
| Geffner Michael | Chief Medical Officer | 2025-07-09 | SELL | 1,160 | $17.24 | $20K |
| Stout Jay S | Chief Technology Officer | 2025-07-09 | SELL | 1,519 | $17.24 | $26.2K |
| Stout Jay S | Chief Technology Officer | 2025-04-23 | SELL | 1,925 | $14.79 | $28.5K |
| Geffner Michael | Chief Medical Officer | 2025-04-23 | SELL | 2,349 | $14.79 | $34.7K |
| Barnett Eva Renee | CFO | 2025-04-16 | SELL | 2,993 | $14.89 | $44.6K |
| Salzmann Peter | CEO | 2025-04-16 | SELL | 8,321 | $14.89 | $123.9K |
| Salzmann Peter | CEO | 2025-04-09 | SELL | 28,094 | $12.99 | $364.9K |
| Stout Jay S | Chief Technology Officer | 2025-04-09 | SELL | 5,004 | $12.99 | $65K |
| Geffner Michael | Chief Medical Officer | 2025-04-09 | SELL | 6,169 | $12.99 | $80.1K |
| Barnett Eva Renee | CFO | 2025-04-09 | SELL | 11,063 | $12.99 | $143.7K |
| Fromkin Andrew J. | Director | 2025-03-07 | SELL | 8,000 | $19.6 | $156.8K |
| Macias William L. | Chief Medical Officer | 2025-02-19 | SELL | 2,055 | $20.86 | $42.9K |
| Barnett Eva Renee | CFO | 2025-02-19 | SELL | 2,814 | $20.86 | $58.7K |
| Salzmann Peter | CEO | 2025-02-19 | SELL | 15,439 | $20.86 | $322.1K |
| Stout Jay S | Chief Technology Officer | 2025-01-22 | SELL | 2,195 | $23.59 | $51.8K |
| Geffner Michael | Chief Medical Officer | 2025-01-22 | SELL | 2,657 | $23.59 | $62.7K |
| Barnett Eva Renee | CFO | 2025-01-15 | SELL | 2,298 | $23.83 | $54.8K |
| Salzmann Peter | CEO | 2025-01-15 | SELL | 8,767 | $23.83 | $208.9K |
| Macias William L. | Chief Medical Officer | 2025-01-15 | SELL | 2,383 | $23.83 | $56.8K |
| Roivant Sciences Ltd. | Director, 10% Owner | 2025-01-13 | BUY | 16,845,010 | $20 | $336900.2K |
| Barnett Eva Renee | CFO | 2025-01-08 | SELL | 4,105 | $24.1 | $98.9K |
| Salzmann Peter | CEO | 2025-01-08 | SELL | 5,105 | $24.1 | $123K |
| Pande Atul | Director | 2024-12-02 | SELL | 7,750 | $28.54 | $221.2K |
| Hughes Douglas J. | Director | 2024-12-02 | SELL | 5,425 | $28.54 | $154.8K |
| Levine Mark S. | Chief Legal Officer | 2024-11-20 | SELL | 3,650 | $25.45 | $92.9K |
| Macias William L. | Chief Medical Officer | 2024-11-20 | SELL | 3,353 | $25.45 | $85.3K |
| Barnett Eva Renee | CFO | 2024-11-20 | SELL | 4,174 | $25.45 | $106.2K |
| Salzmann Peter | CEO | 2024-11-20 | SELL | 16,692 | $25.45 | $424.8K |
| Levine Mark S. | Chief Legal Officer | 2024-10-23 | SELL | 4,361 | $29.53 | $128.8K |
| Geffner Michael | Chief Medical Officer | 2024-10-23 | SELL | 3,189 | $29.53 | $94.2K |
| Stout Jay S | Chief Technology Officer | 2024-10-23 | SELL | 2,740 | $29.53 | $80.9K |
| Salzmann Peter | CEO | 2024-10-16 | SELL | 9,095 | $28.79 | $261.8K |
| Macias William L. | Chief Medical Officer | 2024-10-16 | SELL | 3,188 | $28.79 | $91.8K |
| Levine Mark S. | Chief Legal Officer | 2024-10-16 | SELL | 2,860 | $28.79 | $82.3K |
| Barnett Eva Renee | CFO | 2024-10-16 | SELL | 3,271 | $28.79 | $94.2K |
| Barnett Eva Renee | CFO | 2024-10-09 | SELL | 5,162 | $29.56 | $152.6K |
| Salzmann Peter | CEO | 2024-10-09 | SELL | 4,460 | $29.56 | $131.8K |
| Levine Mark S. | Chief Legal Officer | 2024-08-21 | SELL | 3,295 | $31.86 | $105K |
| Macias William L. | Chief Medical Officer | 2024-08-21 | SELL | 3,027 | $31.86 | $96.4K |
| Barnett Eva Renee | CFO | 2024-08-21 | SELL | 3,768 | $31.86 | $120K |
| Butchko Julia G. | Chief Development Officer | 2024-08-21 | SELL | 3,027 | $31.86 | $96.4K |
| Salzmann Peter | CEO | 2024-08-21 | SELL | 15,068 | $31.86 | $480.1K |
| Stout Jay S | Chief Technology Officer | 2024-07-24 | SELL | 2,813 | $27.76 | $78.1K |
| Geffner Michael | Chief Medical Officer | 2024-07-24 | SELL | 3,456 | $27.76 | $95.9K |
| Levine Mark S. | Chief Legal Officer | 2024-07-24 | SELL | 4,015 | $27.76 | $111.5K |
| Levine Mark S. | Chief Legal Officer | 2024-07-17 | SELL | 2,505 | $29.69 | $74.4K |
| Macias William L. | Chief Medical Officer | 2024-07-17 | SELL | 3,044 | $29.69 | $90.4K |
| Barnett Eva Renee | CFO | 2024-07-17 | SELL | 3,123 | $29.69 | $92.7K |
| Butchko Julia G. | Chief Development Officer | 2024-07-17 | SELL | 2,867 | $29.69 | $85.1K |
| Salzmann Peter | CEO | 2024-07-17 | SELL | 8,685 | $29.69 | $257.9K |
| Barnett Eva Renee | CFO | 2024-07-09 | SELL | 4,747 | $28.06 | $133.2K |
| Butchko Julia G. | Chief Development Officer | 2024-07-09 | SELL | 1,527 | $28.06 | $42.8K |
| Salzmann Peter | CEO | 2024-07-09 | SELL | 4,619 | $28.06 | $129.6K |
| Barnett Eva Renee | CFO | 2024-05-22 | SELL | 4,042 | $29.65 | $119.8K |
| Salzmann Peter | CEO | 2024-05-22 | SELL | 16,163 | $29.65 | $479.2K |
| Butchko Julia G. | Chief Development Officer | 2024-05-22 | SELL | 3,247 | $29.65 | $96.3K |
| Macias William L. | Chief Medical Officer | 2024-05-22 | SELL | 3,247 | $29.65 | $96.3K |
| Levine Mark S. | Chief Legal Officer | 2024-05-22 | SELL | 3,242 | $29.65 | $96.1K |
| Geffner Michael | Chief Medical Officer | 2024-04-24 | SELL | 3,261 | $28.9 | $94.2K |
| Stout Jay S | Chief Technology Officer | 2024-04-24 | SELL | 7,239 | $28.9 | $209.2K |
| Levine Mark S. | Chief Legal Officer | 2024-04-24 | SELL | 3,963 | $28.9 | $114.5K |
| Levine Mark S. | Chief Legal Officer | 2024-04-17 | SELL | 9,827 | $29.06 | $285.6K |
| Macias William L. | Chief Medical Officer | 2024-04-17 | SELL | 8,280 | $29.06 | $240.6K |
| Barnett Eva Renee | CFO | 2024-04-17 | SELL | 12,253 | $29.06 | $356.1K |
| Butchko Julia G. | Chief Development Officer | 2024-04-17 | SELL | 10,115 | $29.06 | $293.9K |
| Salzmann Peter | CEO | 2024-04-17 | SELL | 34,079 | $29.06 | $990.3K |
| Barnett Eva Renee | CFO | 2024-04-09 | SELL | 3,689 | $31.18 | $115K |
| Butchko Julia G. | Chief Development Officer | 2024-04-09 | SELL | 1,053 | $31.18 | $32.8K |
| Salzmann Peter | CEO | 2024-04-09 | SELL | 4,807 | $31.18 | $149.9K |
| Barnett Eva Renee | CFO | 2024-02-22 | SELL | 2,930 | $36.15 | $105.9K |
| Salzmann Peter | CEO | 2024-02-22 | SELL | 13,454 | $36.15 | $486.4K |
| Macias William L. | Chief Medical Officer | 2024-02-22 | SELL | 2,221 | $36.15 | $80.3K |
| Butchko Julia G. | Chief Development Officer | 2024-02-22 | SELL | 2,146 | $36.15 | $77.6K |
| Levine Mark S. | Chief Legal Officer | 2024-02-22 | SELL | 2,134 | $36.15 | $77.1K |
| Levine Mark S. | Chief Legal Officer | 2024-01-26 | SELL | 3,027 | $37.92 | $114.8K |
| Geffner Michael | Chief Medical Officer | 2024-01-26 | SELL | 10,101 | $37.92 | $383K |
| Macias William L. | Chief Medical Officer | 2024-01-18 | SELL | 424 | $41.03 | $17.4K |
| Barnett Eva Renee | CFO | 2024-01-11 | SELL | 3,515 | $41.83 | $147K |
| Butchko Julia G. | Chief Development Officer | 2024-01-05 | SELL | 1,297 | $38.59 | $50.1K |
| Salzmann Peter | CEO | 2024-01-05 | SELL | 3,824 | $38.59 | $147.6K |
| MIGAUSKY GEORGE V | Director | 2023-12-01 | SELL | 12,700 | $39.73 | $504.6K |
| Fromkin Andrew J. | Director | 2023-12-01 | SELL | 12,350 | $39.73 | $490.7K |
| Pande Atul | Director | 2023-12-01 | SELL | 12,350 | $39.73 | $490.7K |
| Salzmann Peter | CEO | 2023-11-22 | SELL | 16,217 | $32.78 | $531.6K |
| Barnett Eva Renee | CFO | 2023-11-22 | SELL | 4,055 | $32.78 | $132.9K |
| Butchko Julia G. | Chief Development Officer | 2023-11-22 | SELL | 3,265 | $32.78 | $107K |
| Macias William L. | Chief Medical Officer | 2023-11-22 | SELL | 3,265 | $32.78 | $107K |
| Levine Mark S. | Chief Legal Officer | 2023-11-22 | SELL | 3,252 | $32.78 | $106.6K |
| Levine Mark S. | Chief Legal Officer | 2023-10-25 | SELL | 4,107 | $34.66 | $142.3K |
| Macias William L. | Chief Medical Officer | 2023-10-19 | SELL | 530 | $36.8 | $19.5K |
| Barnett Eva Renee | CFO | 2023-10-10 | SELL | 4,557 | $36.92 | $168.2K |
| Butchko Julia G. | Chief Development Officer | 2023-10-05 | SELL | 1,735 | $36.24 | $62.9K |
| Salzmann Peter | CEO | 2023-10-05 | SELL | 5,239 | $36.24 | $189.9K |
| Roivant Sciences Ltd. | Director, 10% Owner | 2023-10-02 | BUY | 1,526,316 | $38 | $58000K |
| Salzmann Peter | CEO | 2023-08-30 | SELL | 56,774 | $22.02 | $1250.2K |
| Butchko Julia G. | Chief Development Officer | 2023-08-24 | SELL | 12,333 | $20.3 | $250.4K |
| Macias William L. | Chief Medical Officer | 2023-08-24 | SELL | 12,333 | $20.3 | $250.4K |
| Levine Mark S. | Chief Legal Officer | 2023-08-24 | SELL | 12,286 | $20.3 | $249.4K |
| Barnett Eva Renee | CFO | 2023-08-24 | SELL | 14,386 | $20.3 | $292K |
| Salzmann Peter | CEO | 2023-08-14 | SELL | 103,058 | $21.42 | $2207.5K |
| Salzmann Peter | CEO | 2023-08-07 | SELL | 101,339 | $21.73 | $2202.1K |
| Levine Mark S. | Chief Legal Officer | 2023-07-26 | SELL | 3,917 | $21.63 | $84.7K |
| Macias William L. | Chief Medical Officer | 2023-07-19 | SELL | 426 | $24.94 | $10.6K |
| Barnett Eva Renee | CFO | 2023-07-19 | SELL | 2,725 | $24.94 | $68K |
| Salzmann Peter | CEO | 2023-07-12 | SELL | 3,233 | $19.73 | $63.8K |
| Butchko Julia G. | Chief Development Officer | 2023-07-12 | SELL | 1,470 | $19.73 | $29K |
| Macias William L. | Chief Medical Officer | 2023-04-25 | SELL | 509 | $16.29 | $8.3K |
| Levine Mark S. | Chief Legal Officer | 2023-04-25 | SELL | 2,633 | $16.29 | $42.9K |
| Barnett Eva Renee | CFO | 2023-04-18 | SELL | 3,423 | $15.27 | $52.3K |
| Butchko Julia G. | Chief Development Officer | 2023-04-18 | SELL | 1,544 | $15.27 | $23.6K |
| Salzmann Peter | CEO | 2023-04-18 | SELL | 3,395 | $15.27 | $51.8K |
| Macias William L. | Chief Medical Officer | 2023-02-02 | SELL | 537 | $18.24 | $9.8K |
| Levine Mark S. | Chief Legal Officer | 2023-01-26 | SELL | 10,156 | $18.51 | $188K |
| Salzmann Peter | CEO | 2023-01-11 | SELL | 4,021 | $16.8 | $67.6K |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 2023-01-11 | SELL | 60,490 | $16.79 | $1015.6K |
| Barnett Eva Renee | CFO | 2023-01-11 | SELL | 4,510 | $16.75 | $75.5K |
| Macias William L. | Chief Medical Officer | 2023-01-11 | SELL | 44,568 | $16.75 | $746.5K |
| Macias William L. | Chief Medical Officer | 2022-10-21 | SELL | 341 | $9.67 | $3.3K |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 2022-10-13 | SELL | 928 | $9.18 | $8.5K |
| Salzmann Peter | CEO | 2022-10-13 | SELL | 2,793 | $9.18 | $25.6K |
| Barnett Eva Renee | CFO | 2022-10-11 | SELL | 12,500 | $9.44 | $118K |
| Roivant Sciences Ltd. | 10% Owner | 2022-10-06 | BUY | 416,667 | $6 | $2500K |
| Torti Frank | Director | 2022-09-29 | BUY | 20,000 | $5.81 | $116.2K |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 2022-09-28 | SELL | 535 | $4.67 | $2.5K |
| Salzmann Peter | CEO | 2022-09-28 | SELL | 1,605 | $4.67 | $7.5K |
| Salzmann Peter | CEO | 2022-08-30 | SELL | 1,644 | $5.83 | $9.6K |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 2022-08-30 | SELL | 548 | $5.83 | $3.2K |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 2022-07-27 | SELL | 510 | $4.27 | $2.2K |
| Salzmann Peter | CEO | 2022-07-27 | SELL | 1,528 | $4.27 | $6.5K |
| Macias William L. | Chief Medical Officer | 2022-07-22 | SELL | 322 | $4.7 | $1.5K |
| Salzmann Peter | CEO | 2022-06-29 | SELL | 1,376 | $4.02 | $5.5K |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 2022-06-29 | SELL | 460 | $4.02 | $1.8K |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 2022-05-24 | SELL | 492 | $3.79 | $1.9K |
| Salzmann Peter | CEO | 2022-05-24 | SELL | 1,471 | $3.79 | $5.6K |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 2022-04-27 | SELL | 541 | $4.72 | $2.6K |
| Salzmann Peter | CEO | 2022-04-27 | SELL | 1,622 | $4.72 | $7.7K |
| Macias William L. | Chief Medical Officer | 2022-04-19 | SELL | 1,392 | $4.98 | $6.9K |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 2022-03-24 | SELL | 6,381 | $5.9 | $37.6K |
| Salzmann Peter | CEO | 2022-03-24 | SELL | 19,227 | $5.9 | $113.4K |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 2022-01-07 | SELL | 55,318 | $7.25 | $401.1K |
| Barnett Eva Renee | CFO | 2022-01-07 | SELL | 29,959 | $7.25 | $217.2K |
| Salzmann Peter | CEO | 2022-01-07 | SELL | 125,158 | $7.25 | $907.4K |
| Macias William L. | Chief Medical Officer | 2022-01-05 | SELL | 26,813 | $8.28 | $222K |
| Hughes Douglas J. | Director | 2021-08-27 | BUY | 18,247 | $8.24 | $150.4K |
| MIGAUSKY GEORGE V | Director | 2021-08-20 | BUY | 7,000 | $7.65 | $53.6K |
| Pande Atul | Director | 2021-08-13 | BUY | 5,000 | $7.98 | $39.9K |
| Fromkin Andrew J. | Director | 2021-08-10 | BUY | 5,500 | $7.9 | $43.5K |
| Butchko Julia G. | Chief Dev. & Tech. Officer | 2020-09-11 | BUY | 5,000 | $38.17 | $190.9K |
| Roivant Sciences Ltd. | 10% Owner | 2020-09-04 | BUY | 380,000 | $33 | $12540K |
| Roivant Sciences Ltd. | 10% Owner | 2020-04-16 | BUY | 1,034,483 | $14.5 | $15000K |
| WONG RODERICK | CEO | 2019-12-11 | BUY | 31,500 | $10.92 | $344K |
| WONG RODERICK | CEO | 2019-12-10 | BUY | 25,971 | $10.38 | $269.6K |
| WONG RODERICK | CEO | 2019-12-06 | BUY | 400,000 | $10.25 | $4100K |
| WONG RODERICK | CEO | 2019-12-06 | BUY | 50,000 | $10.2 | $510K |
| WONG RODERICK | CEO | 2019-12-05 | BUY | 20,000 | $10.15 | $203K |
| WONG RODERICK | CEO | 2019-12-04 | BUY | 20,000 | $10.15 | $203K |
| WONG RODERICK | CEO | 2019-12-03 | BUY | 66,918 | $10.36 | $693.3K |
| WONG RODERICK | CEO | 2019-11-27 | BUY | 12,000 | $10.49 | $125.9K |
| WONG RODERICK | CEO | 2019-11-22 | BUY | 46,999 | $10.4 | $488.8K |
| WONG RODERICK | CEO | 2019-11-19 | BUY | 72,610 | $10.26 | $745K |
| WONG RODERICK | CEO | 2019-11-14 | BUY | 126,000 | $10.17 | $1281.4K |
| WONG RODERICK | CEO | 2019-11-11 | BUY | 30,500 | $10.18 | $310.5K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked